Chronic Lymphocytic Leukaemia in the Netherlands: Trends in incidence, treatment and survival, 1989-2008

European Journal of Cancer

Volumn 48, Issue 6, 2012, Pages 889-895

  Van Den Broek, E C ^a   Kater, A P ^b   Van De Schans, S A M ^a,c   Karim Kos, H E ^d   Janssen Heijnen, M L G ^a,d   Peters, W G ^e   Nooijen, P T G A ^f   Coebergh, J W W ^a,d   Posthuma, E F M ^g  

^a The Netherlands   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Integraal Kankercentrum Oost   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e CATHARINA HOSPITAL   (Netherlands)

^f JEROEN BOSCH HOSPITAL   (Netherlands)

^g REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

Chronic Lymphocytic Leukaemia; Epidemiology; Incidence; Registries; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; CANCER THERAPY; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NETHERLANDS; PRIORITY JOURNAL; REGISTRATION; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; TREND STUDY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NETHERLANDS; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 84859107157     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.06.053     Document Type: Article

References (29)

1. http://seer.cancer.gov/.
2. P. Abrisqueta, A. Pereira, and C. Rozman Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience Blood 114 2009 2044 2050
3. B. Eichhorst, V. Goede, and M. Hallek Treatment of elderly patients with chronic lymphocytic leukemia Leuk Lymphoma 50 2 2009 171 178
4. H. Brenner, A. Gondos, and D. Pulte Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century Blood 111 10 2008 4916 4921
5. J.M. Bennett, D. Catovsky, and M.T. Daniel Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group J Clin Pathol 42 6 1989 567 584 (Pubitemid 19156426)
6. A.C. Rawstron Monoclonal B-cell lymphocytosis Hematol Am Soc Hematol Educ Program 2009 430 439
7. F. Ricci, A. Tedeschi, E. Morra, and M. Montillo Fludarabine in the treatment of chronic lymphocytic leukemia: a review Ther Clin Risk Manag 5 1 2009 187 207
8. D. Catovsky, S. Richards, and E. Matutes Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial Lancet 370 9583 2007 230 239 (Pubitemid 47069536)
9. M. Hallek, K. Fischer, and G. Fingerle-Rowson Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial Lancet 376 9747 2010 1164 1174
10. www.ikcnet.nl.
11. A. Fritz, C. Percy, and A. Jack International classification of diseases for oncology 3rd ed. 2000 World Health Organisation Geneva
12. H. Brenner, O. Gefeller, and T. Hakulinen A computer program for period analysis of cancer patient survival Eur J Cancer 38 5 2002 690 695 (Pubitemid 34251393)
13. P.W. Dickman, A. Sloggett, M. Hills, and T. Hakulinen Regression models for relative survival Stat Med 23 1 2004 51 64 (Pubitemid 38072106)
14. M. Sant, C. Allemani, and C. Tereanu Incidence of hematological malignancies in Europe by morphological subtype: results of the HAEMACARE project Blood 116 2010 3724 3734
15. G.M. Dores, W.F. Anderson, and R.E. Curtis Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology Br J Haematol 139 5 2007 809 819 (Pubitemid 350115721)
16. L.C. Thygesen, O.J. Nielsen, and C. Johansen Trends in adult leukemia incidence and survival in Denmark, 1943-2003 Cancer Causes Control 20 9 2009 1671 1680
17. J.D. Otten, M.J. Broeders, and J. Fracheboud Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006 Int J Cancer 123 8 2008 1929 1934
18. K.D. Bertakis, R. Azari, L.J. Helms, E.J. Callahan, and J.A. Robbins Gender differences in the utilization of health care services J Fam Pract 49 2 2000 147 152
19. R.G. Cremers, H.E. Karim-Kos, and S. Houterman Prostate cancer: trends in incidence, survival and mortality in the Netherlands, 1989-2006 Eur J Cancer 46 11 2010 2077 2087
20. S. Molica Sex differences in incidence and outcome of chronic lymphocytic leukemia patients Leuk Lymphoma 47 8 2006 1477 1480 (Pubitemid 44364010)
21. B. Eichhorst, M. Hallek, and M. Dreyling Chronic lymphocytic leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 19 Suppl. 2 2008 ii60 ii62
22. B. Eichhorst, M. Hallek, and M. Dreyling Chronic lymphocytic leukemia: ESMO minimum clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 Suppl. 4 2009 102 104
23. B.D. Cheson, J.M. Bennett, and M. Grever National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment Blood 87 12 1996 4990 4997 (Pubitemid 26189840)
24. A.P. Kater, and S.H. Tonino Standards for the treatment of relapsed chronic lymphocytic leukemia: a case-based study Clin Lymphoma Myeloma Leuk 10 Suppl. 1 2010 S34 S41
25. S.Y. Kristinsson, P.W. Dickman, and W.H. Wilson Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden Haematologica 94 9 2009 1259 1265
26. T.D. Shanafelt, N.E. Kay, and T.G. Call MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count ≥5 × 10(9) L(-1) but a B-cell lymphocyte count 5 × 10(9) L(-1)? Leuk Res 32 9 2008 1458 1461
27. M. Hallek, B.D. Cheson, and D. Catovsky Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines Blood 111 12 2008 5446 5456
28. C.S. Zent, M.J. Kyasa, R. Evans, and S.A. Schichman Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data Cancer 92 5 2001 1325 1330
29. van de Schans SA, Issa DE, Visser O, et al. Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989-2007. Ann Oncol [Epub ahead of print].